Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Breast Neoplasms 6Overweight 2Obesity 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Sexual Dysfunctions, Psychological 1Ovarian Neoplasms 1Depressive Disorder, Major 1

Interventions

Trastuzumab 2Radiotherapy 2Methods 2Early Intervention, Educational 2Behavior Therapy 2tipifarnib 1entinostat 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Ritonavir 1Quality of Life 1Psychiatric Rehabilitation 1Patient Reported Outcome Measures 1Nivolumab 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Interleukin-12 Subunit p35 1Interleukin-12 1Indinavir 1Immunotherapy 1Hysterectomy 1Gene Rearrangement 1Gene Expression Profiling 1Fluorodeoxyglucose F18 1Fentanyl 1FAPI-46 1Educational Status 1Drug Therapy 1Dehydroepiandrosterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vaginal Neoplasms × Bupropion × Breast × Clear all
NCT03180294 2026-05-19

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

NRG Oncology

Phase 2 Completed
230 enrolled 24 charts
BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡